Gland Pharma (GLAND)
FAST GROWERFairStock Score: 62/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,798 |
| Market Cap | ₹30,021.91 Cr |
| P/E Ratio | 34.74 |
| ROCE | 11.89% |
| ROE | 9.26% |
| Dividend Yield | 0.99% |
| Profit Growth | 20.27% |
| Debt/Equity | 0.03 |
| Sales Growth | 6.7% |
| Free Cash Flow | ₹2,63,300 Cr |
| Promoter Holding | 51.83% |
| 52-Week Range | ₹1,573.6 — ₹2,395 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹555.41 |
Gland Pharma trades with a P/E ratio of 34.74, ROCE of 11.89%, ROE of 9.26%, profit growth of 20.27%, debt-to-equity of 0.03. The FairStock Score of 62/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer